Innovaccer
Last reviewed
Jun 8, 2026
Sources
13 citations
Review status
Source-backed
Revision
v1 · 1,722 words
Improve this article
Add missing citations, update stale details, or suggest a clearer explanation.
Suggest edit
CtrlK
Last reviewed
Jun 8, 2026
Sources
13 citations
Review status
Source-backed
Revision
v1 · 1,722 words
Add missing citations, update stale details, or suggest a clearer explanation.
Innovaccer Inc. is a healthcare technology company that builds a data platform and an expanding suite of artificial intelligence tools for hospitals, health systems, payers, government agencies, and life sciences organizations. Its core product unifies fragmented clinical, operational, and financial data from disparate sources, such as electronic health record systems, claims feeds, and labs, into a longitudinal patient record, and then activates that data for population health management, value-based care, analytics, and patient engagement. The company has historically marketed this offering as the "Healthcare Intelligence Cloud" and, more recently, as an agentic platform branded the "Agentic Cloud for Healthcare." [1][2][3]
Founded in 2014 and headquartered in San Francisco, California, Innovaccer is a late-stage private company that reached a "decacorn"-adjacent valuation of roughly $3.45 billion in its January 2025 Series F round. [3][4] It is frequently named among the leading candidates for a health technology initial public offering, although management has signaled that an IPO is not imminent. [5][6] In 2025 and 2026 the company repositioned around healthcare AI, launching AI agents and copilots for clinical and administrative workflows and restructuring its workforce around what it describes as "AI-native" operations. [7][8]
Innovaccer was incorporated in 2014 by Abhinav Shashank, who serves as chief executive officer, along with co-founders Kanav Hasija and Sandeep Gupta. [3][9] Shashank is an alumnus of the Indian Institute of Technology Kharagpur, and the company's origins have been traced to an academic project linked to Harvard University and the Wharton School of the University of Pennsylvania. [3][9] The founders' central thesis was that fragmented, siloed patient data was the primary structural obstacle to improving outcomes and reducing cost in U.S. healthcare, and they set out to build an end-to-end cloud platform to unify it. The platform was initially called "Innovation Accelerator," which was shortened to "Innovaccer." [9]
Although headquartered in San Francisco, Innovaccer maintains substantial operations in India. Its Noida facility supports sales and operations, and the company runs significant research and development and engineering teams in India. [10] The company grew rapidly through the late 2010s and early 2020s on the back of adoption by large U.S. provider organizations, and it expanded its product footprint through several acquisitions, including the healthcare customer relationship management firm Cured (2024), Pharmacy Quality Solutions (2024), actuarial analytics firm Humbi AI (2025), and virtual cardiovascular care company Story Health (2025). [2]
The company has also undergone repeated restructuring. It cut roughly 15 percent of its workforce, about 245 people, in early 2023, and in May 2026 it laid off approximately 340 employees across India and the United States as part of a shift toward AI-native operations, with management citing AI automation of workflows that previously required larger teams. [8]
Innovaccer's platform is organized around a data foundation, a set of domain applications, and an emerging agentic layer. The data foundation, branded Gravity and launched in May 2025, is a cloud-agnostic data and AI infrastructure layer that the company has built in conjunction with partners including Databricks and Snowflake. [2] On top of that foundation sit domain-specific applications. Reporting and the company's own materials describe applications spanning population health, payer risk and quality analytics, revenue cycle automation, and patient engagement and CRM. [2]
The company says its platform serves a large share of the U.S. provider market. At the time of the Series F it reported that six of the ten largest U.S. health systems were customers and that the platform supported more than 130 healthcare organizations; the company has also cited unified data covering tens of millions of patient records. [3][4] Earlier disclosures around its 2021 Series E stated that its software had been deployed across more than 1,000 care settings, enabling more than 37,000 providers and unifying records for more than 24 million people. [1]
The table below summarizes representative product lines as described by the company and trade press. Product names and packaging have evolved over time.
| Product / line | Function |
|---|---|
| Gravity | Cloud-agnostic data and AI platform (the data and intelligence layer) |
| Population health applications | Care management, risk stratification, value-based care |
| Payer analytics | Risk adjustment and quality measurement for health plans |
| Revenue cycle automation | Administrative and billing workflow automation |
| Cured (CRM) | Patient engagement and customer relationship management |
| Sara | AI assistant and copilot family for healthcare roles |
Innovaccer's strategy has shifted decisively toward AI. The company first introduced an AI assistant named Sara at the HIMSS conference in 2023, positioning it as a tool that generates analytic insights about population health data through natural-language responses, and later expanded it into a broader package of large language model tools targeting different healthcare roles. [7] It subsequently added Sara Scribe, an ambient AI tool that transcribes, analyzes, and summarizes provider-patient conversations in ambulatory settings, prepares encounter notes, and integrates with major EHR systems. [4][7]
In 2025 the company launched copilots and AI agents aimed at both clinical and administrative work. In April 2025 it announced copilots and agents for care management, reporting early results of a 28 percent reduction in documentation time and a 20 percent increase in patient engagement, and it rolled out a suite of pretrained, voice-enabled agents that can communicate with patients for tasks such as appointment scheduling, intake, and referral management. [7] The agent suite has been described as also addressing prior authorization, care-gap closure, hierarchical condition category (HCC) coding, and transitional care management. [7] CEO Abhinav Shashank has framed the company's ambition as becoming "a one-stop shop for healthcare AI solutions," to be achieved through a combination of in-house development and acquisitions, with planned additions including an AI medical scribe, a prior authorization tool, and a denied-claims assistant. [3][4]
Innovaccer has raised approximately $675 million in venture and strategic capital across its history. [2][4] Funding figures and lead investors are reported by the company and trade press and are summarized below; the company is privately held, so valuations reflect round disclosures rather than public market prices.
| Round | Date | Amount | Reported valuation | Lead / notable investors |
|---|---|---|---|---|
| Series E | December 2021 | $150M | $3.2B | Led by Mubadala Capital; B Capital, M12, Tiger Global, Steadview, Dragoneer, OMERS, Whale Rock, Avidity, Schonfeld [1] |
| Series F | January 2025 | $275M | ~$3.45B (post-money, primary) | Kaiser Permanente, B Capital Group, Banner Health, Danaher Ventures, Generation IM, M12 [3][4] |
The Series E, announced December 15, 2021, was led by Mubadala Capital and roughly tripled the company's valuation to $3.2 billion. [1] The Series F was announced January 9, 2025, and totaled $275 million in a combination of primary and secondary capital; roughly 35 percent of the proceeds (about $96 million) provided liquidity to seed and Series A investors, with the remainder serving as primary growth capital at a post-money valuation of approximately $3.45 billion. [3][4] Strategic healthcare investors, including Kaiser Permanente and Banner Health, participated alongside venture firms. [3][4] (The starting characterization of a "$275M Series F" is accurate, but the round closed in January 2025, not December 2024, and was anchored by strategic healthcare investors rather than a single venture lead.)
In January 2026 the company completed an employee stock buyback of roughly 600 crore Indian rupees (about $75 million), providing liquidity to current and former employees holding vested options and restricted stock units. [11]
Innovaccer is widely listed as a potential 2026 health-technology IPO candidate, appearing on multiple watchlists of late-stage digital health companies. [5][6] However, the available reporting does not confirm a public or confidential IPO registration. CEO Abhinav Shashank has stated that the company will not pursue an IPO seriously until it is generating roughly $400 million to $500 million in annual recurring revenue; at the time of the Series F the company said it was on track for about $250 million in ARR in 2025 and had sustained roughly 50 percent annual revenue growth for five consecutive years. [4] Accordingly, claims of an imminent or filed IPO should be treated as unverified.
Innovaccer competes in the market for healthcare data platforms, population health management, and value-based care analytics. Its most frequently cited competitors include Health Catalyst, a publicly traded data and analytics vendor founded in 2008 and based in Utah, and Arcadia, a Boston-based population health and data platform founded in 2002. [12][13] Other named competitors and adjacent players include Redox and PatientIQ. [12][13] In the broader landscape, Innovaccer's data-unification and analytics positioning also overlaps with offerings such as Palantir's Foundry for health and the embedded analytics capabilities of major EHR vendors such as Epic. In independent KLAS evaluations of value-based care and analytics platforms, Innovaccer has appeared alongside Epic and Arcadia among the higher-rated vendors. [13]
The company's significance lies in its position as one of the largest late-stage private companies built specifically around healthcare data activation and, increasingly, applied healthcare AI, with adoption among a meaningful share of the largest U.S. health systems and a strategy centered on agentic automation of clinical and administrative workflows. [2][3]